Cargando…
FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin(® )added to standard therapy in patients with lung cancer
BACKGROUND: Venous thromboembolism (VTE) occurs when blood clots in the leg, pelvic or other deep vein (deep vein thrombosis) with or without transport of the thrombus into the pulmonary arterial circulation (pulmonary embolus). VTE is common in patients with cancer and is increased by surgery, chem...
Autores principales: | Griffiths, Gareth O, Burns, Sarah, Noble, Simon I, Macbeth, Fergus R, Cohen, David, Maughan, Timothy S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761945/ https://www.ncbi.nlm.nih.gov/pubmed/19807917 http://dx.doi.org/10.1186/1471-2407-9-355 |
Ejemplares similares
-
Control of actin filament length by phosphorylation of fragmin-actin complex
Publicado: (1990) -
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer
por: Jones, P H, et al.
Publicado: (2004) -
Fragmin induces tension reduction of actomyosin threads in the
presence of micromolar levels of Ca2+
Publicado: (1983) -
Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily
por: Qian, Dong, et al.
Publicado: (2015) -
CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial
por: Fennell, Dean A., et al.
Publicado: (2018)